XML 259 R232.htm IDEA: XBRL DOCUMENT v3.21.2
Restatement of Previously Issued Financial Statements (Details) - Schedule of impact of restatement on balance sheet, statement of operations and statements of cash flows - CIK0001814821 KISMET ACQUISITION ONE CORP [Member] - USD ($)
 1 Months Ended 3 Months Ended 4 Months Ended 6 Months Ended 7 Months Ended
Jun. 30, 2020
Jun. 30, 2021
Mar. 31, 2021
Sep. 30, 2020
Sep. 30, 2020
Jun. 30, 2021
Dec. 31, 2020
Dec. 31, 2020
Aug. 10, 2020
Jun. 02, 2020
Total assets   $ 250,451,845       $ 250,451,845 $ 251,235,286 $ 251,235,286    
Total current liabilities   2,686,384       2,686,384 736,222 736,222    
Derivative warrant liabilities   8,100,000       8,100,000 7,492,500 7,492,500    
Total liabilities   19,536,384       19,536,384 16,978,722 16,978,722    
Ordinary shares, no par value; unlimited shares authorized; 22,925,656 shares subject to possible redemption at 10.00 per share   225,915,460       225,915,460 229,256,560 229,256,560    
Preferred shares, no par value; unlimited shares authorized; none issued and outstanding            
Ordinary shares, no par value; unlimited shares authorized; 8,824,344 shares issued and outstanding (excluding 22,925,656 shares subject to possible redemption)   11,323,159       11,323,159 7,982,059 7,982,059    
Accumulated deficit   (6,323,158)       (6,323,158) (2,982,055) (2,982,055)    
Total shareholders' equity $ 14,780 5,000,001 $ 5,000,006     5,000,001 5,000,004 5,000,004   $ 0
Total liabilities and shareholders' equity   250,451,845       250,451,845 251,235,286 251,235,286    
General and administrative expenses 10,220 527,580       $ 2,757,314 787,645      
Net gain from investments held in Trust Account             64,000      
Net income (loss) (10,220) $ (3,153,845) $ (187,258)       $ (3,000,000.0)      
Weighted average shares outstanding of ordinary shares, basic and diluted (in Shares)   25,000,000       25,000,000 25,000,000      
Basic and diluted net loss per share, ordinary shares (in Dollars per share)   $ 0.00       $ 0.00 $ 0.00      
Net income (loss) (10,220) $ (3,153,845)       $ (3,341,103) $ (2,982,055) (2,982,055)    
Change in fair value of warrant liabilities   $ 2,632,500       607,500 2,227,500      
Net cash used in operating activities (5)         (752,965) (564,227)      
Net cash used in investing activities             (250,000,000)      
Net cash provided by financing activities 550           251,325,750      
Net change in cash 545         (752,965)        
Offering costs paid by Sponsor in exchange for issuance of ordinary shares 25,000           25,000      
Offering costs included in accrued expenses $ 27,560           70,000      
Deferred underwriting commissions             8,750,000      
Initial value of ordinary shares subject to possible redemption             232,178,130      
Change in value of ordinary shares subject to possible redemption           $ (3,341,100) (2,921,570)      
As Previously Reported [Member]                    
Total assets       $ 251,441,956 $ 251,441,956   251,235,286 251,235,286 $ 251,994,299  
Total current liabilities       388,082 388,082   736,222 736,222 801,165  
Other offering costs       8,750,000 8,750,000   8,750,000 8,750,000 8,750,000  
Total liabilities       9,138,082 9,138,082   9,486,222 9,486,222 9,551,165  
Ordinary shares, no par value; unlimited shares authorized; 22,925,656 shares subject to possible redemption at 10.00 per share       237,303,870 237,303,870   236,749,060 236,749,060 237,443,130  
Ordinary shares, no par value; unlimited shares authorized; 8,824,344 shares issued and outstanding (excluding 22,925,656 shares subject to possible redemption)       5,188,763 5,188,763   5,743,573 5,743,573 5,049,504  
Accumulated deficit       (188,759) (188,759)   (743,569) (743,569) (49,500)  
Total shareholders' equity       5,000,004 5,000,004   5,000,004 5,000,004 5,000,004  
Total liabilities and shareholders' equity       251,441,956 251,441,956   251,235,286 251,235,286 251,994,299  
General and administrative expenses       173,275 183,495   787,645      
Administrative fee - related party       20,000 20,000   20,000      
Loss from operations       (193,275) (203,495)   (807,645)      
Net gain from investments held in Trust Account       14,736 14,736   64,076      
Net income (loss)       $ (178,539) $ (188,759)   $ (743,569)      
Weighted average shares outstanding of Founder Shares, basic and diluted (in Shares)       6,750,000 6,750,000   6,750,000      
Basic and diluted net income (loss) per share, Founder Shares (in Dollars per share)       $ (0.03) $ (0.03)   $ (0.12)      
Weighted average shares outstanding of ordinary shares, basic and diluted (in Shares)       25,000,000 25,000,000   25,000,000      
Net income (loss)             $ (743,569)      
Net cash used in operating activities         $ (412,696)   (564,227)      
Net cash used in investing activities         (250,000,000)   (250,000,000)      
Net cash provided by financing activities         251,344,656   251,325,750      
Net change in cash         931,960   761,523      
Offering costs paid by Sponsor in exchange for issuance of ordinary shares         25,000   25,000      
Offering costs included in accrued expenses         70,000   70,000      
Deferred underwriting commissions         8,750,000   8,750,000      
Initial value of ordinary shares subject to possible redemption         237,443,130   237,443,130      
Change in value of ordinary shares subject to possible redemption         (139,264)   (694,070)      
Restatement Adjustment [Member]                    
Derivative warrant liabilities       $ 5,197,500 5,197,500   7,492,500 7,492,500 5,265,000  
Total liabilities       5,197,500 5,197,500   7,492,500 7,492,500 5,265,000  
Ordinary shares, no par value; unlimited shares authorized; 22,925,656 shares subject to possible redemption at 10.00 per share       (5,197,500) (5,197,500)   (7,492,500) (7,492,500) (5,265,000)  
Ordinary shares, no par value; unlimited shares authorized; 8,824,344 shares issued and outstanding (excluding 22,925,656 shares subject to possible redemption)       (56,514) (56,514)   2,238,486 2,238,486 10,986  
Accumulated deficit       56,514 56,514   (2,238,486) (2,238,486) (10,986)  
Change in fair value of derivative warrant liabilities       67,500 67,500   (2,227,500)      
Offering costs associated with issuance of derivative warrant liabilities       (10,986) (10,986)   (10,986)      
Net income (loss)       $ 56,514 $ 56,514   $ (2,238,486)      
Basic and diluted net income (loss) per share, Founder Shares (in Dollars per share)       $ 0.01 $ 0.01   $ (0.33)      
Net income (loss)             $ (2,238,486)      
Change in fair value of warrant liabilities         $ (67,500)   2,227,500      
Offering costs associated with issuance of private warrants         10,986   10,986      
Net cash used in operating activities         0          
Net change in cash         0   0      
Initial value of ordinary shares subject to possible redemption         (5,265,000)   (5,265,000)      
Change in value of ordinary shares subject to possible redemption         67,504   (2,227,500)      
As Restated [Member]                    
Total assets       $ 251,441,956 251,441,956   251,235,286 251,235,286 251,994,299  
Total current liabilities       388,082 388,082   736,222 736,222 801,165  
Other offering costs       8,750,000 8,750,000   8,750,000 8,750,000 8,750,000  
Derivative warrant liabilities       5,197,500 5,197,500   7,492,500 7,492,500 5,265,000  
Total liabilities       14,335,582 14,335,582   16,978,722 16,978,722 14,816,165  
Ordinary shares, no par value; unlimited shares authorized; 22,925,656 shares subject to possible redemption at 10.00 per share       232,106,370 232,106,370   229,256,560 229,256,560 232,178,130  
Ordinary shares, no par value; unlimited shares authorized; 8,824,344 shares issued and outstanding (excluding 22,925,656 shares subject to possible redemption)       5,132,249 5,132,249   7,982,059 7,982,059 5,060,490  
Accumulated deficit       (132,245) (132,245)   (2,982,055) (2,982,055) (60,486)  
Total shareholders' equity       5,000,004 5,000,004   5,000,004 5,000,004 5,000,004  
Total liabilities and shareholders' equity       251,441,956 251,441,956   251,235,286 $ 251,235,286 $ 251,994,299  
General and administrative expenses       173,275 183,495   787,645      
Administrative fee - related party       20,000 20,000   20,000      
Loss from operations       (193,275) (203,495)   (807,645)      
Change in fair value of derivative warrant liabilities       67,500 67,500   (2,227,500)      
Offering costs associated with issuance of derivative warrant liabilities       (10,986) (10,986)   (10,986)      
Net gain from investments held in Trust Account       14,736 14,736   64,076      
Net income (loss)       $ (122,025) $ (132,245)   $ (2,982,055)      
Weighted average shares outstanding of Founder Shares, basic and diluted (in Shares)       6,750,000 6,750,000   6,750,000      
Basic and diluted net income (loss) per share, Founder Shares (in Dollars per share)       $ (0.02) $ (0.02)   $ (0.45)      
Weighted average shares outstanding of ordinary shares, basic and diluted (in Shares)       25,000,000 25,000,000   25,000,000      
Basic and diluted net loss per share, ordinary shares (in Dollars per share)       $ 0.00 $ 0.00   $ 0.00      
Net income (loss)             $ (2,982,055)      
Change in fair value of warrant liabilities         $ (67,500)   2,227,500      
Offering costs associated with issuance of private warrants         10,986   10,986      
Net cash used in operating activities         (412,696)   (564,227)      
Net cash used in investing activities         (250,000,000)   (250,000,000)      
Net cash provided by financing activities         251,344,656   251,325,750      
Net change in cash         931,960   761,523      
Offering costs paid by Sponsor in exchange for issuance of ordinary shares         25,000   25,000      
Offering costs included in accrued expenses         70,000   70,000      
Deferred underwriting commissions         8,750,000   8,750,000      
Initial value of ordinary shares subject to possible redemption         232,178,130   232,178,130      
Change in value of ordinary shares subject to possible redemption         $ (71,760)   $ (2,921,570)